瑞健集團(SHL)成立於1989年，目標以西方管理模式在亞洲打造具有國際水準的生產中心。如今，在全球製藥及生物科技領域，SHL已成為藥物輸送系統的OEM/ODM領導製造商，如自動安全注射器。除此之外，SHL還擴展許多產品線，像是軟性結構類醫療產品、醫療氣墊床、醫療床、腦神經手術器具、工業 設備和醫療用吊昇設備等，目標市場為北美、歐洲及亞洲。

SHL (Scandinavian Health Ltd) is currently the world‘s largest privately-owned designer, developer and manufacturer of advanced drug delivery systems. The organization was established in 1989 by Swedish entrepreneurs Roger Samuelsson and Martin Jelf with the goal of combining world-class manufacturing in Asia with the strengths of Western Management practices.
SHL manufactures devices including pen injectors, auto injectors and inhaler systems. We also manufacture a range of other products including pressure mattress systems, patient lifting slings, medical soft goods, beds, neurosurgical devices, catheters and industrial equipment.

經營理念
* 承諾 Commitment
對客戶的承諾是我們成功的基石。我們致力提供客製化且全方位的解決方案來滿足客戶的個別需求。
Commitment to our customer is one of the cornerstones of our success. SHL strives to provide solutions that have been fully customized to meet individual customer requirements.
* 品質 Quality
品質保證是我們的基本原則，也是生產製程的核心部分，高品質的產品是SHL Group對客戶的保證。
Quality at SHL is a fundamental part of our organization and is built into the core of processes. This ensures that the products we manufacture meet customer requirements without compromise.
* 專業 Professionalism
我們在各階段的商業合作關係中皆秉持一貫的專業性，此為SHL Group在亞洲成為國際級製造商的主因。
Professionalism throughout every stage of our business relationships is one of the primary reasons that SHL has such a strong reputation as a world-class manufacturer in Asia.